SiRNA delivery systems based on neutral cross-linked dendrimers

Area of Science:

• Biotechnology
• Nanomedicine
• Gene Therapy

Background:

• Cationic polyamidoamine (PAMAM) dendrimers are often used for siRNA delivery but can exhibit toxicity.
• Modifying dendrimers to achieve neutrality under physiological conditions is crucial for improved biocompatibility.
• Targeting ligands are essential for specific cellular uptake and enhanced therapeutic efficacy.

Purpose of the Study:

• To develop a neutral, cross-linked dendritic system for efficient and targeted small interfering RNA (siRNA) delivery.
• To investigate the role of N-acetylgalactosamine (GalNAc) ligands in cellular interaction and gene silencing.
• To establish a versatile platform for siRNA delivery with tunable properties.

Main Methods:

• Transformation of cationic PAMAM dendrimers into neutral glycosylated carriers by replacing terminal amines with hydrazide groups and GalNAc ligands.
• Development of pH-sensitive, cross-linked dendritic systems using glutaraldehyde for siRNA complexation at pH 5.
• In vitro evaluation of cellular uptake, biocompatibility, and RNA interference (RNAi) efficacy in HepG2 cells.

Main Results:

• Successfully created neutral, cross-linked dendritic systems capable of complexing siRNA at acidic pH.
• Demonstrated that the particulate properties of the carriers are tunable by cross-linking conditions and GalNAc level.
• Observed effective in vitro cellular uptake by HepG2 cells and significant inhibition of luciferase reporter gene expression with optimized GalNAc content.

Conclusions:

• Neutral cross-linked dendritic systems represent a promising new platform for biocompatible and targeted siRNA delivery.
• The GalNAc modification enhances specific interaction with target cells, improving gene silencing efficiency.
• This approach offers a versatile strategy for developing advanced nanocarriers for gene therapy applications.